Statement on new testing results, including low levels of impurities in ranitidine drugs
Americans deserve to have confidence in the quality of drugs the U.S. Food and Drug Administration regulates — from the prescription medicines they take to the over-the-counter (OTC) products they use in their daily lives. Helping assure the quality and safety of these products is one of our greatest responsibilities. Over the past several weeks, the FDA has been investigating the detection of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications, commonly known by the brand name Zantac.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063